−0.17 CNY
−373.37 M CNY
1.12 B CNY
1.30 B
About HUNAN ER-KANG PHAR
Sector
Industry
CEO
Qingrong Sun
Website
Headquarters
Changsha
Founded
2003
ISIN
CNE100001781
FIGI
BBG0021SXB10
Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. It offers pharmaceutical excipients, active pharmaceutical ingredients (API) and pharmaceutical preparation. The pharmaceutical excipients produce glycerol, medicinal alcohol, propylene glycol, medicinal sodium hydroxide and medical sucrose. The API includes glycerol, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium and calamine powder. The pharmaceutical preparation provides sulbenicillin sodium injection and compound liquorice tablets. The company was founded by Fang Wen Shuai on October 22, 2003 and is headquartered in Changsha, China.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300267 is 4.24 CNY — it has decreased by −9.59% in the past 24 hours. Watch HUNAN ER-KANG PHAR stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUNAN ER-KANG PHAR stocks are traded under the ticker 300267.
300267 stock has risen by 18.11% compared to the previous week, the month change is a 27.71% rise, over the last year HUNAN ER-KANG PHAR has showed a 90.13% increase.
300267 reached its all-time high on Jun 5, 2015 with the price of 23.25 CNY, and its all-time low was 1.23 CNY and was reached on Jan 17, 2012. View more price dynamics on 300267 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300267 stock is 13.27% volatile and has beta coefficient of 1.73. Track HUNAN ER-KANG PHAR stock price on the chart and check out the list of the most volatile stocks — is HUNAN ER-KANG PHAR there?
Today HUNAN ER-KANG PHAR has the market capitalization of 8.75 B, it has increased by 2.65% over the last week.
Yes, you can track HUNAN ER-KANG PHAR financials in yearly and quarterly reports right on TradingView.
300267 net income for the last quarter is 28.11 M CNY, while the quarter before that showed −347.90 M CNY of net income which accounts for 108.08% change. Track more HUNAN ER-KANG PHAR financial stats to get the full picture.
As of Aug 3, 2025, the company has 1.45 K employees. See our rating of the largest employees — is HUNAN ER-KANG PHAR on this list?
Like other stocks, 300267 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUNAN ER-KANG PHAR stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUNAN ER-KANG PHAR technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUNAN ER-KANG PHAR stock shows the buy signal. See more of HUNAN ER-KANG PHAR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.